跳至主要内容
临床试验/NCT05952050
NCT05952050招募中不适用

Effect of Different Administration Routes of Dexmedetomidine on Postoperative Delirium in Elderly Patients Undergoing General Anesthesia

Boston Intelligent Medical Research Center, Shenzhen United Scheme Technology Co., Ltd.1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2023年8月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
120
试验地点
1
主要终点
The frequency of delirium during the first 3 postoperative days

研究概览

简要总结

Intravenous dexmedetomidine has been reported to decrease the occurrence of postoperative delirium (POD) in elderly patients. Nevertheless, some previous studies have indicated that intratracheal dexmedetomidine and intranasal dexmedetomidine are also effective and convenient. The current study aimed to compare the effect of different administration routes of dexmedetomidine on POD in elderly patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
65 Years 至 99 Years(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Older than 65 years; General anesthesia for more than two hours;

排除标准

  • 未提供

研究组 & 干预措施

Intranasal dexmedetomidine

Experimental

干预措施: Dexmedetomidine (Drug)

Intravenous dexmedetomidine

Active Comparator

干预措施: Dexmedetomidine (Drug)

结局指标

主要结局

The frequency of delirium during the first 3 postoperative days

时间窗: 3 days

次要结局

  • The incidence of sleep quality(3 days)
  • The incidence of postoperative sore throat(3 days)

研究者

发起方
Boston Intelligent Medical Research Center, Shenzhen United Scheme Technology Co., Ltd.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Different Administration Routes of Dexmedetomidine... | 临床试验